Dupilumab for immune checkpoint inhibitors‐induced pruritic dermatoses: A retrospective, multicentric study

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2025-10-16
DOI
https://doi.org/10.1111/jdv.70122
Citations
2
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
2.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dupilumab for immune checkpoint inhibitors‐induced pruritic dermatoses: A retrospective, multicentric study

Konstantinos Lallas, Chrysa Oikonomou, Azael Freites‐Martínez, Vasiliki A. Nikolaou et al.
2 citations
Journal of the European Academy of Dermatology and Venereology
Cancer Immunotherapy and Biomarkers
2.09
article

Dupilumab for immune checkpoint inhibitors‐induced pruritic dermatoses: A retrospective, multicentric study

Konstantinos Lallas, Chrysa Oikonomou, Azael Freites‐Martínez, Vasiliki A. Nikolaou, Priscila Giavedoni, Florentina Delli, Lukas Kraehenbuehl, Célèste Lebbé, Dimitra Koumaki, Thierry Passeron, Cristina Carrera, Ana Clara Torre, Pietro Sollena, Davide Fattore, Yannick S. Elshot, Francesca Bruni, Damien Giacchero, Julia Riganti, Alicia Jiménez Antón, Jesse Hirner, E. Gérard, Olivier Gaide, V. Sibaud, Zoé Apalla, Michela Valeria Rita Starace, Emma Huard, Johana Rousset
article en
2 citations

Abstract

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Journal of the European Academy of Dermatology and Venereology
Inserm (FR), National and Kapodistrian University of Athens (GR), University of Zurich (CH), Université Paris Cité (FR), Aristotle University of Thessaloniki (GR), Dutch Cancer Society (NL), University of Missouri Health System (US), General University Hospital of Patras (GR), Saint Louis University Hospital (US), Centre Hospitalier Universitaire Vaudois (CH), Hospital Italiano de Buenos Aires (AR), Agostino Gemelli University Polyclinic (IT), The Netherlands Cancer Institute (NL), Centre Hospitalier Universitaire de Bordeaux (FR), Centre Hospitalier Universitaire de Nice (FR), Institut universitaire du cancer de Toulouse Oncopole (FR), University Hospital of Zurich (CH), Oncode Institute (NL), Hospital Clínic de Barcelona (ES), Hôpital Orthopédique de la Suisse Romande (CH), Ippokrateio General Hospital of Thessaloniki (GR), Centre Méditerranéen de Médecine Moléculaire (FR), Azienda USL di Bologna (IT), Institut de Recherche sur le Cancer et le Vieillissement de Nice (FR), University Hospital of Heraklion (GR), Hôpital Pasteur (FR), Hôpital Saint-Louis (FR), Hospital Universitario Puerta del Mar (ES), Amsterdam University Medical Centers (NL), University of Naples Federico II (IT), University of Amsterdam (NL), Universidad Europea de Madrid (ES), University of Bologna (IT), University of Lausanne (CH)
Openalex Percentile: Top 10%
Cancer Immunotherapy and Biomarkers
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.